Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA)Vaccines (Basel), 2023-04, Vol.11 (4), p.852 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11040852 ;PMID: 37112764Full text available |
|
2 |
Material Type: Article
|
Immunogenicity and Safety of Anti-SARS-CoV-2 mRNA Vaccines in a Cohort of Patients with Hereditary AngioedemaVaccines (Basel), 2023-01, Vol.11 (2), p.215 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11020215 ;PMID: 36851094Full text available |
|
3 |
Material Type: Article
|
Ocular Complications Following Vaccination for COVID-19: A One-Year RetrospectiveVaccines (Basel), 2022-02, Vol.10 (2), p.342 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10020342 ;PMID: 35214800Full text available |
|
4 |
Material Type: Article
|
Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines—A Case SeriesVaccines (Basel), 2021-11, Vol.9 (11), p.1349 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111349 ;PMID: 34835280Full text available |
|
5 |
Material Type: Article
|
Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic ReviewVaccines (Basel), 2021-11, Vol.9 (12), p.1404 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121404 ;PMID: 34960150Full text available |
|
6 |
Material Type: Article
|
Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 VaccinationVaccines (Basel), 2021-09, Vol.9 (9), p.974 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9090974 ;PMID: 34579211Full text available |
|
7 |
Material Type: Article
|
COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 PatientsVaccines (Basel), 2022-10, Vol.10 (10), p.1758 [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10101758 ;PMID: 36298623Full text available |
|
8 |
Material Type: Article
|
Sweet Syndrome Following SARS-CoV2 VaccinationVaccines (Basel), 2021-11, Vol.9 (11), p.1212 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111212 ;PMID: 34835143Full text available |
|
9 |
Material Type: Article
|
A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 VaccineVaccines (Basel), 2021-09, Vol.9 (10), p.1108 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9101108 ;PMID: 34696214Full text available |
|
10 |
Material Type: Article
|
Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 VaccinationVaccines (Basel), 2022-04, Vol.10 (4), p.575 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10040575 ;PMID: 35455324Full text available |
|
11 |
Material Type: Article
|
Dual Corneal-Graft Rejection after mRNA Vaccine (BNT162b2) for COVID-19 during the First Six Months of Follow-Up: Case Report, State of the Art and Ethical ConcernsVaccines (Basel), 2021-11, Vol.9 (11), p.1274 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111274 ;PMID: 34835205Full text available |
|
12 |
Material Type: Article
|
Anthrax Vaccines in the 21st CenturyVaccines (Basel), 2024-02, Vol.12 (2), p.159 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12020159 ;PMID: 38400142Full text available |
|
13 |
Material Type: Article
|
New-Onset Acute Kidney Disease Post COVID-19 VaccinationVaccines (Basel), 2022-05, Vol.10 (5), p.742 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10050742 ;PMID: 35632497Full text available |
|
14 |
Material Type: Article
|
Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy ReportVaccines (Basel), 2023-01, Vol.11 (1), p.142 [Peer Reviewed Journal]2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11010142 ;PMID: 36679987Full text available |
|
15 |
Material Type: Article
|
Toxicological Assessments of a Pandemic COVID-19 Vaccine-Demonstrating the Suitability of a Platform Approach for mRNA VaccinesVaccines (Basel), 2023-02, Vol.11 (2), p.417 [Peer Reviewed Journal]COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines11020417 ;PMID: 36851293Full text available |
|
16 |
Material Type: Article
|
Herpetic Keratitis Preceded by COVID-19 VaccinationVaccines (Basel), 2021-11, Vol.9 (12), p.1394 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9121394 ;PMID: 34960139Full text available |
|
17 |
Material Type: Article
|
Parsonage-Turner Syndrome following COVID-19 Vaccination: A Systematic ReviewVaccines (Basel), 2024-03, Vol.12 (3), p.306 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12030306 ;PMID: 38543940Full text available |
|
18 |
Material Type: Article
|
Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy AdultVaccines (Basel), 2022-01, Vol.10 (1), p.87 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10010087 ;PMID: 35062748Full text available |
|
19 |
Material Type: Article
|
Right Biceps Pseudo-Tumor from COVID-19 VaccinationVaccines (Basel), 2024-02, Vol.12 (2), p.160 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2024 by the authors. 2024 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12020160 ;PMID: 38400143Full text available |
|
20 |
Material Type: Article
|
COVID Vaccine-Associated Myocarditis in Adolescent Siblings: Does It Run in the Family?Vaccines (Basel), 2022-04, Vol.10 (4), p.611 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines10040611 ;PMID: 35455360Full text available |